Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-30 @ 12:23 PM
Study NCT ID:
NCT00871156
Status:
COMPLETED
Last Update Posted:
2017-06-19
First Post:
2009-03-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tafenoquine/Chloroquine DDI Study
Sponsor:
GlaxoSmithKline
Organization:
Study Overview
Official Title:
Safety, Tolerability, and Pharmacokinetic Study of Concomitant Chloroquine and Tafenoquine in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
DDI study of Tafenoquine and Chloroquine
Detailed Description:
Safety, Tolerability, and Pharmacokinetic Study of Concomitant Chloroquine and Tafenoquine in Healthy Volunteers
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: